CXCR4 expression affects overall survival of HCC patients whereas CXCR7 expression does not

Cellular and Molecular Immunology

Volumn 12, Issue 4, 2015, Pages 474-482

  Neve Polimeno, Maria ^a   Ierano, Caterina ^a   D'Alterio, Crescenzo ^a   Losito, Nunzia Simona ^a   Napolitano, Maria ^a   Portella, Luigi ^a   Scognamiglio, Giosuè ^a   Tatangelo, Fabiana ^a   Trotta, Anna Maria ^a   Curley, Steven ^b   Costantini, Susan ^c   Liuzzi, Raffaele ^d   Izzo, Francesco ^a   Scala, Stefania ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF TEXAS   (United States)

^c CROM Centro Ricerche Oncologiche Mercogliano   (Italy)

^d CNR   (Italy)

Author keywords

CXCL12; CXCR4; CXCR7; hepatocellular carcinoma; prognosis

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR7; MESSENGER RNA; PLERIXAFOR; CHEMOKINE RECEPTOR CXCR; CXCR4 PROTEIN, HUMAN; CXCR7 PROTEIN, HUMAN; TUMOR PROTEIN;

ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CELL INVASION; CELL MIGRATION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TUMOR VOLUME; UPREGULATION; ADULT; AGED; BIOSYNTHESIS; DISEASE FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION; HEP-G2 CELL LINE; IMMUNOLOGY; LIVER TUMOR; MALE; METABOLISM; MIDDLE AGED; MORTALITY; SURVIVAL RATE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; RECEPTORS, CXCR; RECEPTORS, CXCR4; SURVIVAL RATE;

EID: 84936141104     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2014.102     Document Type: Article

References (41)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics (2007). CA Cancer J Clin 2007; 57: 43-66
2. Malhi H, Gores GJ. Cellular and molecular mechanisms of liver injury. Gastroenterology 2008; 134: 1641-1654
3. Wald O, Weiss ID, Galun E, Peled A. Chemokines in hepatitis C virus infection: pathogenesis, prognosis and therapeutics. Cytokine 2007; 39: 50-62
4. Huang F, Geng XP. Chemokines and hepatocellular carcinoma. World J Gastroenterol 2010; 16: 1832-1836
5. Li W, Gomez E, Zhang Z. Immunohistochemical expression of stromal cell-derived factor-1 (SDF-1) and CXCR4 ligand receptor system in hepatocellular carcinoma. J Exp Clin Cancer Res 2007; 26: 527-533
6. Liu H, Pan Z, Li A. Roles of chemokine receptor 4 (CXCR4) and chemokine ligand 12 (CXCL12) in metastasis of hepatocellular carcinoma cells. Cell Mol Immunol 2008; 5: 373-378
7. Schimanski CC, Bahre R, Gockel I. Dissemination of hepatocellular carcinoma is mediated via chemokine receptor CXCR4. Br J Cancer 2006; 95: 210-217
8. Xiang ZL, Zeng ZC, Tang ZY, Fan J, Zhuang PY, Liang Y, et al. Chemokine receptor CXCR4 expression in hepatocellular carcinoma patients increases the risk of bone metastases and poor survival. BMC Cancer 2009; 9: 176
9. Xiang Z, Zeng Z, Tang Z, Fan J, Sun H, Wu W, et al. Increased expression of vascular endothelial growth factor-C and nuclear CXCR4 in hepatocellular carcinoma is correlated with lymph node metastasis and poor outcome. Cancer J 2009; 15: 519-525
10. Monnier J, Boissan M, LHelgoualch A. CXCR7 is up-regulated in human and murine hepatocellular carcinoma and is specifically expressed by endothelial cells. Eur J Cancer 2012; 48: 138-148
11. Zheng K, Li HY, Su XL, Wang XY, Tian T, Li F, et al. Chemokine receptor CXCR7 regulates the invasion, angiogenesis and tumor growth of human hepatocellular carcinoma cells. J Exp Clin Cancer Res 2010; 29: 31
12. Balabanian K, Lagane B, Infantino S. The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. J Biol Chem 2005; 280: 35760-35766
13. Miao Z, Luker KE, Summers BC CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-Associated vasculature. Proc Natl Acad Sci USA 2007; 104: 15735-15740
14. Wang J, Shiozawa Y, Wang J. The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer. J Biol Chem 2008; 283: 4283-4294
15. Tarnowski M, Grymula K, Reca R. Regulation of expression of stromalderived factor-1 receptors: CXCR4 and CXCR7 in human rhabdomyosarcomas. Mol Cancer Res 2010; 8: 1-14
16. Hattermann K, Held-Feindt J, Lucius R. The chemokine receptor CXCR7 is highly expressed in human glioma cells and mediates antiapoptotic effects. Cancer Res 2010; 70: 3299-3308
17. Müller A, Homey B, Soto H. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001; 410: 50-56
18. Murphy PM. The molecular biology of leukocyte chemoattractant receptors. Annu Rev Immunol 1994; 12: 593-633
19. Taichman RS, Cooper C, Keller ET, Pienta KJ, Taichman NS, McCauley LK. Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res 2002; 62: 1832-1837
20. Burns JM, Summers BC, Wang Y, Melikian A, Berahovich R, Miao Z, et al. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J Exp Med 2006; 203: 2201-2213
21. Thelen M, Thelen S. CXCR7, CXCR4 and CXCL12, an eccentric trio? J Neuroimmunol 2008; 198: 9-13
22. Sierro F, Biben C, Martínez-Muñoz L, Mellado M, Ransohoff RM, Li M, et al. Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7. Proc Natl Acad Sci USA 2007; 104: 14759-14764
23. Grymula K, Tarnowski M, Wysoczynski M, Drukala J, Barr FG, Ratajczak J, et al. Overlapping and distinct role of CXCR7-SDF-1/ITAC and CXCR4-SDF-1 axes in regulating metastatic behavior of human rhabdomyosarcomas. Int J Cancer 2010; 127: 2554-2568
24. Hou KL, Hao MG, Bo JJ, Wang JH. CXCR7 in tumorigenesis and progression. Chin J Cancer 2010; 29: 456-459
25. Zabel BA, Wang Y, Lewén S, Berahovich RD, Penfold ME, Zhang P, et al. Elucidation of CXCR7-mediated signaling events and inhibition of CXCR4-mediated tumor cell transendothelial migration by CXCR7 ligands. J Immunol 2009; 183: 3204-3211
26. Iwakiri S, Mino N, Takahashi T, Sonobe M, Nagai S, Okubo K, et al. Higher expression of chemokine receptor CXCR7 is linked to early and metastatic recurrence in pathological stage I nonsmall cell lung cancer. Cancer 2009; 115: 2580-2593
27. DAlterio C, Consales C, Polimeno M, Franco R, Cindolo L, Portella L, et al. Concomitant CXCR4 and CXCR7 expression predicts poor prognosis in renal cancer. Curr Cancer Drug Targets 2010; 10: 772-781
28. Portella L, Vitale R, de Luca S, DAlterio C, Ieranò C, Napolitano M, et al. Preclinical development of a novel class of CXCR4 antagonist impairing solid tumors growth and metastases. PLoS One 2013; 13: 8
29. Mitra P, De A, Ethier MF, Mimori K, Kodys K, Shibuta K, et al. Loss of chemokine SDF-1alpha-mediated CXCR4 signalling and receptor internalization in human hepatoma cell line HepG2. Cell Signal 2001; 13: 311-319
30. Fedyk ER, Ryan DH, Ritterman I, Springer TA. Maturation decreases responsiveness of human bone marrow B lineage cells to stromalderived factor 1 (SDF-1). J Leuk Biol 1999; 66: 667-673
31. Honczarenko M, Douglas RS, Mathias C, Lee B, Ratajczak MZ, Silberstein LE. SDF-1 responsiveness does not correlate with CXCR4 expression levels of developing human bone marrow B cells. Blood 1999; 94: 2990-2998
32. Sutton A, Friand V, Brulé-Donneger S, Chaigneau T, Ziol M, Sainte-Catherine O, et al. Stromal cell-derived factor-1/chemokine (C-X-C motif) ligand 12 stimulates human hepatoma cell growth, migration, and invasion. Mol Cancer Res 2007; 5: 21-33
33. Kim SW, Kim HY, Song IC, Jin SA, Lee HJ, Yun HJ, et al. Cytoplasmic trapping of CXCR4 in hepatocellular carcinoma cell lines. Cancer Res Treat 2008; 40: 53-61
34. Kucia M, Reca R, Miekus K, Wanzeck J, Wojakowski W, Janowska-Wieczorek A, et al. Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis. Stem Cells 2005; 23: 879-894
35. Xue TC, Han D, Chen RX, Zou JH, Wang Y, Tang ZY, et al. High expression of CXCR7 combined with Alpha fetoprotein in hepatocellular carcinoma correlates with extrahepatic metastasis to lung after hepatectomy. Asian Pac J Cancer Prev 2011; 12: 657-663
36. Levoye A, Balabanian K, Baleux F, Bachelerie F, Lagane B. CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling. Blood 2009; 113: 6085-6093
37. Rajagopal S, Kim J, Ahn S, Craig S, Lam CM, Gerard NP, et al. Betaarrestin-but notGprotein-mediatedsignaling by the decoyreceptor CXCR7. Proc Natl Acad Sci USA 2010; 107: 628-632
38. Naumann U, Cameroni E, Pruenster M, Mahabaleshwar H, Raz E, Zerwes HG, et al. CXCR7 functionsas a scavenger for CXCL12 and CXCL11. PLoS One 2010; 5: e9175
39. Boldajipour B, Mahabaleshwar H, Kardash E, Reichman-Fried M, Blaser H, Minina S, et al. Control of chemokine-guided cell migration by ligand sequestration. Cell 2008; 132: 463-473
40. Luker KE, Lewin SA, Mihalko LA, Schmidt BT, Winkler JS, Coggins NL, et al. Scavenging of CXCL12 by CXCR7 promotes tumor growth and metastasis of CXCR4-positive breast cancer cells. Oncogene 2012; 31: 4750-4758
41. de Caillot FM, Kazmi MA, Lin Y, Ray-Saha S, Sakmar TP, Sachdev P. CXCR7/CXCR4 heterodimer constitutive lyrecruits beta-Arrestin to enhance cell migration. J Biol Chem 2011; 286: 32188-32197